Literature DB >> 5158198

Effect of glucagon on ventricular arrhythmias after coronary artery occlusion and on ventricular automaticity in the dog.

B R Madan.   

Abstract

1. In anaesthetized dogs, glucagon (100 mug/kg i.v.), caused a significant increase in heart rate and decrease in mean arterial blood pressure. Ventricular automaticity, as determined by the time to the onset of first vagal escape beat and the number of such indioventricular beats during the 30 s period of vagal stimulation, was not significantly altered.2. In unanaesthetized dogs with ventricular arrhythmias produced by two-stage ligation of the anterior descending branch of the left coronary artery, glucagon (30 and 100 mug/kg i.v.), restored normal sinus rhythm in a few animals. In the remaining dogs, there was a significant reduction in the ventricular ectopic activity.3. The significant positive chronotropic response to glucagon elicited in anaesthetized animals was not observed in conscious dogs whose coronary arteries had been ligated.4. These findings enhance the potential usefulness of glucagon in the treatment of acute myocardial infarction, which may often be associated with disturbances of ventricular rhythm.5. In the light of observations made by other workers, it is suggested that the antiarrhythmic effect of glucagon may be due to movement of potassium ions into the cardiac cell.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5158198      PMCID: PMC1665899     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Ventricular arrhythmias induced by sympathomimetic amines in unanesthetized dogs following coronary artery occlusion.

Authors:  H M MALING; N C MORAN
Journal:  Circ Res       Date:  1957-07       Impact factor: 17.367

2.  Arrhythmias following experimental coronary occlusion and their response to drugs.

Authors:  B B CLARK; J R CUMMINGS
Journal:  Ann N Y Acad Sci       Date:  1956-11-16       Impact factor: 5.691

3.  Delayed development of ventricular ectopic rhythms following experimental coronary occlusion.

Authors:  A S HARRIS
Journal:  Circulation       Date:  1950-06       Impact factor: 29.690

Review 4.  The physiologic basis for treatment of shock associated with myocardial infarction.

Authors:  R M Gunnar; R J Pietras; C Stavrakos; H S Loeb; J R Tobin
Journal:  Med Clin North Am       Date:  1967-01       Impact factor: 5.456

5.  Effects of glucose and nonglucose infusions on myocardial potassium ion transfers and arrhythmias during ischemia.

Authors:  W M Burke; S K Asokan; C B Moschos; H A Oldewurtel; T J Regan
Journal:  Am J Cardiol       Date:  1969-11       Impact factor: 2.778

6.  Effects of glucagon on myocardial metabolism in patients with and without coronary artery disease.

Authors:  M G Bourassa; J Eibar; L Campeau
Journal:  Circulation       Date:  1970-07       Impact factor: 29.690

7.  Ventricular arrhythmias and K+ transfer during myocardial ischemia and intervention with procaine amide, insulin, or glucose solution.

Authors:  T J Regan; M A Harman; P H Lehan; W M Burke; H A Oldewurtel
Journal:  J Clin Invest       Date:  1967-10       Impact factor: 14.808

8.  Haemodynamic effects of glucagon.

Authors:  J G Murtagh; P F Binnion; S Lal; K J Hutchison; E Fletcher
Journal:  Br Heart J       Date:  1970-05

9.  Comparison of the inotropic response to glucagon, ouabain and noradrenaline.

Authors:  B Spilker
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

10.  Glucagon and haemodynamics of acute myocardial infarction.

Authors:  J D Eddy; E T O'Brien; S P Singh
Journal:  Br Med J       Date:  1969-12-13
View more
  1 in total

Review 1.  Glucagon and heart in type 2 diabetes: new perspectives.

Authors:  Antonio Ceriello; Stefano Genovese; Edoardo Mannucci; Edoardo Gronda
Journal:  Cardiovasc Diabetol       Date:  2016-08-27       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.